BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Osterlund P, Salminen T, Soveri LM, Kallio R, Kellokumpu I, Lamminmäki A, Halonen P, Ristamäki R, Lantto E, Uutela A, Osterlund E, Ovissi A, Nordin A, Heervä E, Lehtomäki K, Räsänen J, Murashev M, Aroviita L, Jekunen A, Lindvall-Andersson R, Nyandoto P, Kononen J, Lepistö A, Poussa T, Muhonen T, Ålgars A, Isoniemi H; Members of The RAXO study group are collaborators of this study and are listed in Appendix Table 4B. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study. Lancet Reg Health Eur 2021;3:100049. [PMID: 34557799 DOI: 10.1016/j.lanepe.2021.100049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ignatavicius P, Oberkofler CE, Jonas JP, Mullhaupt B, Clavien P. The essential requirements for a HPB center to deliver high quality outcomes. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.04.036] [Reference Citation Analysis]
2 Kempf E, Priou S, Lamé G, Daniel C, Bellamine A, Sommacale D, Belkacemi Y, Bey R, Galula G, Taright N, Tannier X, Rance B, Flicoteaux R, Hemery F, Audureau E, Chatellier G, Tournigand C; on behalf of the Assistance Publique-Hôpitaux de Paris Cancer Group. Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of university hospitals. Int J Cancer 2022. [PMID: 35001364 DOI: 10.1002/ijc.33928] [Reference Citation Analysis]
3 Banchini F, Luzietti E, Palmieri G, Bonfili D, Romboli A, Conti L, Capelli P. Laparoscopic Resection of Synchronous Liver Metastasis Involving the Left Hepatic Vein and the Common Trunk Bifurcation: A Strategy of Parenchyma-Sparing Resection with Left Sectionectomy and 4a Subsegmentectomy by Arantius Approach. Healthcare 2022;10:517. [DOI: 10.3390/healthcare10030517] [Reference Citation Analysis]
4 Osterlund P, Kinos S, Pfeiffer P, Salminen T, Kwakman J, Frödin J, Shah C, Sorbye H, Ristamäki R, Halonen P, Soveri L, Heervä E, Ålgars A, Bärlund M, Hagman H, Mcdermott R, O’reilly M, Röckert R, Liposits G, Kallio R, Flygare P, Teske A, van Werkhoven E, Punt C, Glimelius B. Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study. ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100427] [Reference Citation Analysis]
5 Strohaeker J, Sulyok M, Koenigsrainer A, Nadalin S. Alveolar Echinococcosis-A Challenging Task for the Hepatobiliary Surgeon. Pathogens 2021;11:40. [PMID: 35055988 DOI: 10.3390/pathogens11010040] [Reference Citation Analysis]
6 Hitchcock KE, Romesser PB, Miller ED. Local Therapies in Advanced Colorectal Cancer. Hematol Oncol Clin North Am 2022:S0889-8588(22)00007-7. [PMID: 35562258 DOI: 10.1016/j.hoc.2022.02.007] [Reference Citation Analysis]
7 Treasure T, Farewell V, Macbeth F, Batchelor T, Milosevic M, King J, Zheng Y, Leonard P, Williams NR, Brew-Graves C, Morris E, Fallowfield L; PulMiCC investigators. The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) burden of care study: Analysis of local treatments for lung metastases and systemic chemotherapy in 220 patients in the PulMiCC cohort. Colorectal Dis 2021. [PMID: 34310835 DOI: 10.1111/codi.15833] [Reference Citation Analysis]
8 Eigeliene N, Saarenheimo J, Wichmann V, Österlund P, Jekunen A. Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment. Case Rep Oncol 2021;14:1475-82. [PMID: 34899239 DOI: 10.1159/000519044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Beom SH, Kim JG, Baik SH, Shin SH, Park I, Park YS, Lee MA, Lee S, Jeon SY, Han SW, Kang MH, Oh J, Kim JS, Kim JY, Ahn MS, Zang DY, Bae BN, Jo HJ, Kim HK, Kim JH, Yoon JA, Kim DH. Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen. J Cancer Res Clin Oncol 2022. [PMID: 35344080 DOI: 10.1007/s00432-022-03946-x] [Reference Citation Analysis]
10 Germani MM, Borelli B, Boraschi P, Antoniotti C, Ugolini C, Urbani L, Morelli L, Fontanini G, Masi G, Cremolini C, Moretto R. The management of colorectal liver metastases amenable of surgical resection: How to shape treatment strategies according to clinical, radiological, pathological and molecular features. Cancer Treat Rev 2022;106:102382. [PMID: 35334281 DOI: 10.1016/j.ctrv.2022.102382] [Reference Citation Analysis]
11 Uutela A, Ovissi A, Hakkarainen A, Ristimäki A, Lundbom N, Kallio R, Soveri LM, Salminen T, Ålgars A, Halonen P, Ristamäki R, Nordin A, Blanco Sequeiros R, Rinta-Kiikka I, Lantto E, Virtanen J, Pääkkö E, Liukkonen E, Saunavaara J, Ryymin P, Lammentausta E, Osterlund P, Isoniemi H; RAXO Study Group. Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and 1H-MR spectroscopy compared with histology (subgroup in the RAXO trial). ESMO Open 2021;6:100208. [PMID: 34325107 DOI: 10.1016/j.esmoop.2021.100208] [Reference Citation Analysis]